Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ørestad Kiropraktik & Sundhed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   3.1% 2.0% 2.0% 3.2% 4.9% 2.5% 10.3% 10.3%   Credit score (0-100)   58 70 69 54 44 61 24 24   Credit rating   BBB A A BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,621 4,658 4,739 4,890 4,142 4,568 0.0 0.0   EBITDA   443 898 988 457 211 637 0.0 0.0   EBIT   198 699 746 207 43.0 472 0.0 0.0   Pre-tax profit (PTP)   145.9 660.1 723.8 189.9 12.4 439.6 0.0 0.0   Net earnings   113.8 514.9 542.5 170.2 9.6 342.9 0.0 0.0   Pre-tax profit without non-rec. items   146 660 724 190 12.4 440 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   949 811 668 505 376 368 0.0 0.0   Shareholders equity total   357 661 687 317 101 444 23.9 23.9   Interest-bearing liabilities   656 268 0.0 135 249 23.4 221 221   Balance sheet total (assets)   1,841 1,772 1,770 1,377 1,200 1,199 245 245   Net Debt   643 226 -238 107 224 -85.8 221 221     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,621 4,658 4,739 4,890 4,142 4,568 0.0 0.0   Gross profit growth   23.2% 28.6% 1.7% 3.2% -15.3% 10.3% -100.0% 0.0%   Employees   6 6 6 6 7 7 0 0   Employee growth %   20.0% 0.0% 0.0% 0.0% 16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,841 1,772 1,770 1,377 1,200 1,199 245 245   Balance sheet change%   22.7% -3.7% -0.1% -22.2% -12.8% -0.1% -79.6% 0.0%   Added value   197.8 699.4 745.8 206.6 43.0 472.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   127 -397 -446 -473 -357 -232 -368 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.5% 15.0% 15.7% 4.2% 1.0% 10.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.8% 38.7% 42.1% 13.1% 3.3% 39.3% 0.0% 0.0%   ROI %   19.4% 67.6% 83.7% 31.2% 6.2% 67.8% 0.0% 0.0%   ROE %   27.7% 101.1% 80.5% 33.9% 4.6% 125.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   19.4% 37.3% 38.8% 23.0% 8.4% 37.0% 9.7% 9.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   145.2% 25.1% -24.0% 23.4% 106.2% -13.5% 0.0% 0.0%   Gearing %   183.5% 40.6% 0.0% 42.6% 246.5% 5.3% 926.4% 926.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.1% 8.5% 16.4% 24.6% 16.0% 23.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.2 0.5 0.7 0.5 0.9 1.0 0.0 0.0   Current Ratio   0.2 0.5 0.7 0.5 0.9 1.0 0.0 0.0   Cash and cash equivalent   12.6 42.9 237.5 28.4 25.2 109.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,087.8 -556.5 -318.7 -456.8 -77.8 -2.8 -110.6 -110.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   33 117 124 34 6 67 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   74 150 165 76 30 91 0 0   EBIT / employee   33 117 124 34 6 67 0 0   Net earnings / employee   19 86 90 28 1 49 0 0